Healthcare providers don’t dismiss cannabinoid therapeutics because they don’t work. They dismiss them because no one has handed them serious clinical literature – until now.
Drawing on a background in pharmaceutical sales, I’ve spent years envisioning something that didn’t exist in this space: a credible, physician-grade reference document for cannabinoid therapeutics, formatted and sourced exactly like the PI sheet that comes with every prescription medication. 💊
At Flower & Tonic, we’ve built it.
The Flower & Tonic Clinical Pharmacology Monograph is a physician-reference document covering CBD, CBG, CBC, and CBN, written to the standard of a pharmaceutical package insert.
It covers:
✦ How the Endocannabinoid System works
✦ Mechanisms of action for CBD, CBG, CBC & CBN
✦ Drug-drug interactions (including high-risk combinations)
✦ Dosing guidelines by condition
✦ Pharmacokinetics & bioavailability by delivery route
✦ Clinical evidence levels for key therapeutic indications
Every claim is sourced from peer-reviewed literature, FDA prescribing information, and published pharmacokinetic studies. This isn’t marketing copy.
At Flower & Tonic, we don’t just publish the science — we stand behind it. The products we carry are selected to meet the same standards this monograph describes. We also partner with bloodwork and testing labs so that patients and practitioners can monitor outcomes, adjust protocols, and use cannabinoid therapeutics the way any responsible treatment should be used: with data, not guesswork.
Because “start low and go slow” isn’t good enough anymore.
We welcome collaboration with brands, practitioners, and industry partners who believe cannabinoid therapeutics deserve better science — and better accountability — at the point of care.
📩 contact@flowerandtonic.com